• Using GPCRs as molecular beacons to target ovarian cancer with nanomedicines 

      Khetan, Riya; Dharmayanti, Cintya; Gillam, Todd A.; Kübler, Eric; Klingler-Hoffmann, Manuela; Ricciardelli, Carmela; Oehler, Martin K.; Blencowe, Anton; Garg, Sanjay; Albrecht, Hugo (2022-05-10)
      Cancers
      The five-year survival rate for women with ovarian cancer is very poor despite radical cytoreductive surgery and chemotherapy. Although most patients initially respond to platinum-based chemotherapy, the majority experience ...
      01A - Beitrag in wissenschaftlicher Zeitschrift